Skip to content

Gynatrof® 50mL

by Tyros Biopharma, Inc.

Gynatrof 50mL is a vaginal lubricant (FDA Class II; FDA product code NUC, Lubricant, Personal) made by Tyros Biopharma, Inc., listed in FDA GUDID since 16 Aug 2019 (UDI-DI 00180266000058), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00180266000058 UDI-DI Date16 Aug 2019ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Gynatrof is a personal lubricant, for vaginal and/or penile application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body’s natural lubrication.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Full name
Gynatrof(R) 50mL
Trade name
Gynatrof(R)
Generic name
Vaginal lubricant
Model / reference
50mL
Primary DI / UDI-DI
00180266000058
FDA product code
NUC
GMDN term
Vaginal lubricant
Device class
Class II
Regulation number
884.5300
GUDID distribution status
In Commercial Distribution
Size
Total Volume — 50 Milliliter

Similar devices

Other devices filed under FDA product code NUC (Lubricant, Personal).

Other devices from Tyros Biopharma, Inc.

  • Gynatrof

    Class II

Properties

  • Over-the-counter
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)